Home NDC 66993-209 Axitinib
Product NDC 66993-209
11-digit product format 669930209
Labeler code 66993
Product ID 66993-209_bb8c8051-59d3-4a8e-9d4d-ac5760ffbefa
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name axitinib
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Prasco Laboratories
Application NDA202324
Marketing category NDA AUTHORIZED GENERIC
Marketing start 2026-11-15
Substance AXITINIB
Active strength 5 mg/1
Pharmacologic classes Kinase Inhibitor [EPC], Receptor Tyrosine Kinase Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N202324-001 INLYTA AXITINIB 1MG TABLET / ORAL AB RLD 2012-01-27 N202324-002 INLYTA AXITINIB 5MG TABLET / ORAL AB RLD, RS 2012-01-27
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Orange Book patents# Current patent rows page 1 of 1 · 18 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 90 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 N202324-001 INLYTA 1MG TABLET / ORAL AB RLD 2012-01-27 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202324-002 INLYTA 5MG TABLET / ORAL AB RLD, RS 2012-01-27 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N202324-001 INLYTA 1MG TABLET / ORAL AB RLD 2012-01-27 c2088c7a36db…2026-10-15 13:18:30 2026-09 N202324-002 INLYTA 5MG TABLET / ORAL AB RLD, RS 2012-01-27 c2088c7a36db…2026-09-14 22:38:34 2026-08 N202324-001 INLYTA 1MG TABLET / ORAL RLD 2012-01-27 84e616aacf4f…2026-09-14 22:38:34 2026-08 N202324-002 INLYTA 5MG TABLET / ORAL RLD, RS 2012-01-27 84e616aacf4f…2026-08-18 06:07:40 2026-07 N202324-001 INLYTA 1MG TABLET / ORAL RLD 2012-01-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N202324-002 INLYTA 5MG TABLET / ORAL RLD, RS 2012-01-27 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N202324-001 INLYTA 1MG TABLET / ORAL AB RLD 2012-01-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202324-002 INLYTA 5MG TABLET / ORAL AB RLD, RS 2012-01-27 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N202324-001 INLYTA 1MG TABLET / ORAL AB RLD 2012-01-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N202324-002 INLYTA 5MG TABLET / ORAL AB RLD, RS 2012-01-27 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N202324-001 INLYTA 1MG TABLET / ORAL RLD 2012-01-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N202324-002 INLYTA 5MG TABLET / ORAL RLD, RS 2012-01-27 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N202324-001 INLYTA 1MG TABLET / ORAL RLD 2012-01-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N202324-002 INLYTA 5MG TABLET / ORAL RLD, RS 2012-01-27 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N202324-001 INLYTA 1MG TABLET / ORAL RLD 2012-01-27 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N202324-002 INLYTA 5MG TABLET / ORAL RLD, RS 2012-01-27 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N202324-001 INLYTA 1MG TABLET / ORAL RLD 2012-01-27 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N202324-002 INLYTA 5MG TABLET / ORAL RLD, RS 2012-01-27 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N202324-001 INLYTA 1MG TABLET / ORAL RLD 2012-01-27 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N202324-002 INLYTA 5MG TABLET / ORAL RLD, RS 2012-01-27 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N202324-001 INLYTA 1MG TABLET / ORAL RLD 2012-01-27 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N202324-002 INLYTA 5MG TABLET / ORAL RLD, RS 2012-01-27 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N202324-001 INLYTA 1MG TABLET / ORAL RLD 2012-01-27 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N202324-002 INLYTA 5MG TABLET / ORAL RLD, RS 2012-01-27 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N202324-001 INLYTA 1MG TABLET / ORAL RLD 2012-01-27 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N202324-002 INLYTA 5MG TABLET / ORAL RLD, RS 2012-01-27 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N202324-001 INLYTA 1MG TABLET / ORAL RLD 2012-01-27 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N202324-002 INLYTA 5MG TABLET / ORAL RLD, RS 2012-01-27 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N202324-001 INLYTA 1MG TABLET / ORAL RLD 2012-01-27 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N202324-002 INLYTA 5MG TABLET / ORAL RLD, RS 2012-01-27 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N202324-001 INLYTA 1MG TABLET / ORAL RLD 2012-01-27 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N202324-002 INLYTA 5MG TABLET / ORAL RLD, RS 2012-01-27 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N202324-001 INLYTA 1MG TABLET / ORAL RLD 2012-01-27 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N202324-002 INLYTA 5MG TABLET / ORAL RLD, RS 2012-01-27 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N202324-001 INLYTA 1MG TABLET / ORAL RLD 2012-01-27 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N202324-002 INLYTA 5MG TABLET / ORAL RLD, RS 2012-01-27 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N202324-001 INLYTA 1MG TABLET / ORAL RLD 2012-01-27 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N202324-002 INLYTA 5MG TABLET / ORAL RLD, RS 2012-01-27 5d02ea3f76ae…
Observed Orange Book normalized TE history# Observed Orange Book patent history# Patent history page 1 of 13 · 486 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-11-14 07:37:17 2026-10 N202324-001 8791140 2030-12-14 Drug substance d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202324-001 8791140*PED 2031-06-14 Pediatric extension d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202324-001 10570202 2035-02-03 U-2844 2020-06-30 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202324-001 12534530 2035-02-03 U-4411 2026-02-23 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202324-001 12534530 2035-02-03 U-4412 2026-02-23 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202324-001 10570202*PED 2035-08-03 Pediatric extension d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202324-001 12534530*PED 2035-08-03 Pediatric extension d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202324-001 10869924 2037-01-12 U-3044 2021-01-21 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202324-001 10869924*PED 2037-07-12 Pediatric extension d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202324-002 8791140 2030-12-14 Drug substance d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202324-002 8791140*PED 2031-06-14 Pediatric extension d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202324-002 10570202 2035-02-03 U-2844 2020-06-30 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202324-002 12534530 2035-02-03 U-4411 2026-02-23 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202324-002 12534530 2035-02-03 U-4412 2026-02-23 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202324-002 10570202*PED 2035-08-03 Pediatric extension d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202324-002 12534530*PED 2035-08-03 Pediatric extension d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202324-002 10869924 2037-01-12 U-3044 2021-01-21 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202324-002 10869924*PED 2037-07-12 Pediatric extension d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N202324-001 8791140 2030-12-14 Drug substance c2088c7a36db…2026-10-15 13:18:30 2026-09 N202324-001 8791140*PED 2031-06-14 Pediatric extension c2088c7a36db…2026-10-15 13:18:30 2026-09 N202324-001 10570202 2035-02-03 U-2844 2020-06-30 c2088c7a36db…2026-10-15 13:18:30 2026-09 N202324-001 12534530 2035-02-03 U-4411 2026-02-23 c2088c7a36db…2026-10-15 13:18:30 2026-09 N202324-001 12534530 2035-02-03 U-4412 2026-02-23 c2088c7a36db…2026-10-15 13:18:30 2026-09 N202324-001 10570202*PED 2035-08-03 Pediatric extension c2088c7a36db…2026-10-15 13:18:30 2026-09 N202324-001 12534530*PED 2035-08-03 Pediatric extension c2088c7a36db…2026-10-15 13:18:30 2026-09 N202324-001 10869924 2037-01-12 U-3044 2021-01-21 c2088c7a36db…2026-10-15 13:18:30 2026-09 N202324-001 10869924*PED 2037-07-12 Pediatric extension c2088c7a36db…2026-10-15 13:18:30 2026-09 N202324-002 8791140 2030-12-14 Drug substance c2088c7a36db…2026-10-15 13:18:30 2026-09 N202324-002 8791140*PED 2031-06-14 Pediatric extension c2088c7a36db…2026-10-15 13:18:30 2026-09 N202324-002 10570202 2035-02-03 U-2844 2020-06-30 c2088c7a36db…2026-10-15 13:18:30 2026-09 N202324-002 12534530 2035-02-03 U-4411 2026-02-23 c2088c7a36db…2026-10-15 13:18:30 2026-09 N202324-002 12534530 2035-02-03 U-4412 2026-02-23 c2088c7a36db…2026-10-15 13:18:30 2026-09 N202324-002 10570202*PED 2035-08-03 Pediatric extension c2088c7a36db…2026-10-15 13:18:30 2026-09 N202324-002 12534530*PED 2035-08-03 Pediatric extension c2088c7a36db…2026-10-15 13:18:30 2026-09 N202324-002 10869924 2037-01-12 U-3044 2021-01-21 c2088c7a36db…2026-10-15 13:18:30 2026-09 N202324-002 10869924*PED 2037-07-12 Pediatric extension c2088c7a36db…2026-09-14 22:38:34 2026-08 N202324-001 8791140 2030-12-14 Drug substance 84e616aacf4f…2026-09-14 22:38:34 2026-08 N202324-001 8791140*PED 2031-06-14 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N202324-001 10570202 2035-02-03 U-2844 2020-06-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 N202324-001 12534530 2035-02-03 U-4411 2026-02-23 84e616aacf4f…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Sample Exclude flag Status 66993-209-60 66993020960 60 TABLET, FILM COATED in 1 BOTTLE (66993-209-60) 2026-11-15 No No Historical